Skip to main content
Equibles
RZLT logo

RZLT · Rezolute, Inc.

Track RZLT — free

Use RZLT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RZLT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.56 +0.23 (+5.31%)
Russell 2000 member Rebalance outlook locked
Market Cap
$377.22M
Shares
96.72M
Volume · Oct 5 4.2M Avg daily vol (3M) 1.48M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.33 Open$4.05 Day$3.82–4.54 52W close$1.40–10.94 Avg vol 30d1.5M Short int16.8M · 17.4% float · 14.8d Short vol77% Last earningsMay 20, 2026 DataJan 2020–Oct 2026 Filing10-K · Sep 24

Up next

Latest filing: 10-K
filed Sep 24, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-56.4%
Trailing year
Short interest
17.4%
Latest settlement · 14.8 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Strong Sentiment Bullish Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 15.5 · calm Equity put/call 0.59
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +17%
above
Price vs 50-day avg −3%
below
RSI (14) 53
neutral
MACD trend Positive
52-week position 31%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return −5%
trailing
6-month return +22%
trailing
YTD return +83%
this year
Relative strength +10%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $4 › 200d $4 — 50d above 200d
Institutional flow Accumulating
+15% holders QoQ · +40 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
17.38% of float · ▼ -1.1% MoM · 14.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
147 holders — near 3-yr high, broad support
Squeeze score 73
high risk · 0–100
Fundamentals
Strong
EPS growth +23%
Y/Y
Free cash flow $-64.8M
Balance sheet $27.1M
net cash
Quant / Vol
risk profile
Very High
Volatility 128%
annualized · 1-yr
Max drawdown −87%
past year
ATR 6.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
0 · 5 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+17% Bullish
Price vs 50-day avg
−3% Neutral
RSI (14)
53 Neutral
MACD trend
Positive Bullish
52-week position
31% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $4 › 200d $4 — 50d above 200d
Institutional flow Accumulating
+15% holders QoQ · +40 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
17.38% of float · ▼ -1.1% MoM · 14.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
147 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $1 Now $4 · 31% Range high $11
vs 200-day avg +17% vs 50-day avg -3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Average G&A employees 21 fiscal year ended June 30, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
RZLT
Rezolute, Inc.
this stock
$377.22M +83.5% — — 17.4%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $133.37B +11.1% +46.2% 30.7 1.9%
REGN
Regeneron Pharmaceuticals, Inc.
 $81.13B -5.9% +20.8% 19.5 2.5%
MRNA
Moderna, Inc.
 $79.40B +589.1% +4.3% — 8.2%
CSLLY
Csl Ltd
 $61.25B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
147
% held
92.6%
Net QoQ
+1.7M sh
Top holder
FEDERATED HERMES, INC.
Held Float
View
Held by Funds
Fund positions
144
View
Short & Settlement
Short Interest Falling
Shares short
16.8M
Days to cover
14.8d
Change
-184.3K sh
View
Short Volume
Short vol %
77%
As of
Oct 5, 2026
Short Total
View
Fails to Deliver
FTD shares
1.8K
Value
$8.2K
As of
Sep 4, 2026
View
Off-Exchange
Off-exchange %
37.6%
Week of
Aug 31, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
$-77.6M
EPS diluted
$-0.75
View
Filings
SEC Filings
Latest
8-K
Filed
Oct 5, 2026
This year
12
View
Exempt Offerings
Offering
$57.0M
Filed
Oct 22, 2020
View
Earnings & Events
Webcasts
Last webcast
Jun 4, 2026
View

Performance

5D 20D 120D MTD YTD
RZLT +3.6% -5.5% +22.0% +4.6% +83.5%
SPY +1.2% +0.6% +11.6% +1.6% +13.6%
vs SPY +2.4% -6.1% +10.4% +3.0% +69.9%
Key facts CIK 1509261 CUSIP 76200L309 13F (30d) 3 filings 3 filers Visit website Investor relations